Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Issuance of Common Stock

Arcus Biosciences Inc Issuance of Common Stock Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Issuance of Common Stock from 2017 to 2018.
  • Arcus Biosciences Inc Issuance of Common Stock for the quarter ending December 12, 2018 was $1m a 75.49% increase of 1m year over year
  • Arcus Biosciences Inc Issuance of Common Stock for the last 12 months ending December 12, 2018 was $129m a -0.94% decrease of -1m year over year
  • Arcus Biosciences Inc Annual Issuance of Common Stock for 2018 was $129m a 99.31% increase of 128m from 2017
  • Arcus Biosciences Inc Annual Issuance of Common Stock for 2017 was $1m a 68.27% increase of 1m from 2016
  • Arcus Biosciences Inc Annual Issuance of Common Stock for 2016 was $0m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Issuance of Common Stock Data

12/2018$1m
03/2018$130m
12/2017$0m
09/2017$0m
06/2017$1m
03/2017$0m

Annual RCUS Issuance of Common Stock Data

2018$129m
2017$1m
2016$0m